If side effects are problematic during dose escalation, your prescriber may temporarily pause or reduce your dose
Providing the right kind of lifestyle behavior change support to enable GLP-1 persistence long enough to see benefits can help members achieve clinical trial-level weight loss, setting the stage for cardiometabolic disease risk reduction
Xiao K, Zhang S, Peng Q, Du Y, Yao X, Ng II, et al
Worldwide coverage for living, working, or traveling abroad
Cagrilintide target doses in the combination The optimal cagrilintide dose in the combination context appears to be between 1.0 mg and 2.4 mg weekly based on available data
We offer compassionate care that respects every individuals unique journey by combining advanced medical science with modern technology